Studies on Lysosomal Storage Diseases in Cell Culture: Niemann-Pick Disease Type D

  • M. W. Spence
  • H. W. Cook
  • J. K. Burgess
Conference paper
Part of the NATO ASI Series book series (NSSA, volume 150)

Abstract

The Niemann-Pick group of diseases are characterized by varying degrees of central nervous system involvement, hepatosplenomegaly, foam-cells in the bone marrow, and variably increased amounts of sphingomyelin, cholesterol, glycosphingolipids and bis(monoacylglycero) phosphate in visceral organs (1–6). In some forms of the disease, the primary defect is a deficiency of the lysosomal sphingomyelinase (EC 3.1.4.12 sphingomyelin choline phosphohydrolase) with activity levels less than 10% of normal (2,6,7). In other forms of the disease, sphingomyelin storage is less marked (2,3,5), sphingomyelinase activities are normal or variably reduced (3–7), and abnormalities in cholesterol esterification have been noted in some (8).

Keywords

Cholesterol Hydrolysis Phosphorus Chloroform Trypsin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    D.S. Fredrickson, Sphingomyelin lipidosis: Niemann-Pick disease,in Metabolic Basis of Inherited Disease, J.B. Stanbury, J.B. Wyngaarden, and D.S. Fredrickson (eds). 2 ed. New York: McGraw-Hill Book Co, p. 586. (1966).Google Scholar
  2. 2.
    R.O. Brady, Sphingomyelin lipidoses: Niemann-Pick disease, in Metabolic Basis of Inherited Disease, J.B. Stanbury, J.B. Wyngaarden, D.S. Fredrickson, J.L. Goldstein, and M.S. Brown (eds). 5 ed. New York: McGraw-HiLL Book Co, p. 831. (1983).Google Scholar
  3. 3.
    M.T. Vanier, Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. Biochim Biophys Acta 750:178 (1983).PubMedGoogle Scholar
  4. 4.
    G.T. Besley and M. Elleder, Enzyme activities and phospholipid storage patterns in brain and spleen samples from Niemann-Pick disease variants: a comparison of neuropathic and non-neuropathic forms. J Inherited Metab Dis 9:59 (1986).PubMedCrossRefGoogle Scholar
  5. 5.
    B.G. Rao and M.W. Spence, Niemann-Pick disease type D: lipid analyses and studies on sphingomyelinases. Ann Neurol 1:385 (1977).PubMedCrossRefGoogle Scholar
  6. 6.
    T. Levade, R. Salvayre, and L. Douste-Blazy, Sphingomyelinases and Niemann-Pick disease. J Clin Chem Clin Biochem 24:205 (1986).PubMedGoogle Scholar
  7. 7.
    M.T. Vanier, R. Rousson, I. Garcia, G. Bailloud, M.C. Juge, A. Revol, and P. Louisot, Biochemical studies in Niemann-Pick disease. III. In vitro and in vivo assays of sphingomyelin degradation in cultured skin fibroblasts and amniotic fluid cells for the diagnosis of the various forms of the disease. Clin Genet 27:20 (1985).PubMedCrossRefGoogle Scholar
  8. 8.
    H.S. Kruth, M.E. Comly, J.D. Butler, M.T. Vanier, J.K. Fink, D.A. Wenger, S. Patel, and P.G. Pentchev, Type C Niemann-Pick disease. Abnormal metabolism of low density lipoprotein in homozygous and heterozygous fibroblasts. J Biol Chem 261:16769 (1986).PubMedGoogle Scholar
  9. 9.
    Winsor, E.J., and J.P. Welch, Genetic and demographic aspects of Nova Scotia Niemann-Pick disease (type D). Am J Hum Genet 30:530 (1978).PubMedGoogle Scholar
  10. 10.
    J.A.R. Tibbies and J.P. Welch, Clinical and genetic data on twelve cases of Type D Niemann-Pick disease (Abstr.). Pediatr Res 6:634 (1972).Google Scholar
  11. 11.
    M.W. Spence, J.T. Clarke, and H.W. Cook, Pathways of sphingomyelin metabolism in cultured fibroblasts from normal and sphingomyelin lipidosis subjects. J Biol Chem 258:8595 (1983).PubMedGoogle Scholar
  12. 12.
    A.L. Beaudet and A.A. Manschreck, Metabolism of sphingomyelin by intact cultured fibroblasts: differentiation of Niemann-Pick disease type A and B. Biochem Biophys Res Commun 105:14 (1982).PubMedCrossRefGoogle Scholar
  13. 13.
    S.L. Sutrina and W.W. Chen, Lysosomal involvement in cellular turnover of plasma membrane sphingomyelin. Biochim Biophys Acta 793:169 (1984).PubMedGoogle Scholar
  14. 14.
    J.C. Maziere, C. Maziere, L. Mora, J.D. Routier, and J. Polonovski, In situ degradation of sphingomyelin by cultured normal fibroblasts and fibroblasts from patients with Niemann-Pick disease type A and C. Biochem Biophys Res Commun 108:1101 (1982).PubMedCrossRefGoogle Scholar
  15. 15.
    T. Kudoh, M.A. Velkoff, and D.A. Wenger, Uptake and metabolism of radioactively labeled sphingomyelin in cultured skin fibroblasts from controls and patients with Niemann-Pick disease and other lysosomal storage diseases. Biochim Biophys Acta 754:82 (1983).PubMedGoogle Scholar
  16. 16.
    T. Levade and S. Gatt, Uptake and intracellular degradation of fluorescent sphingomyelin by fibroblasts from normal individuals and a patient with Niemann-Pick disease. Biochim Biophys Acta 918:250 (1987).Google Scholar
  17. 17.
    B.G. Rao and M.W. Spence, Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0. J Lipid Res 17:506 (1976).Google Scholar
  18. 18.
    M.W. Spence, S. Beed, and H.W. Cook, Acid and alkaline ceramidases of rat tissues. Biochem Cell Biol 64:400 (1986).PubMedCrossRefGoogle Scholar
  19. 19.
    O. Lindberg and L. Ernster, Determination of organic phosphorus compounds by phosphate analysis,in Methods of Biochemical Analysis,D.Glick (eds). New York:Interscience Publishers Inc, p. 1. (1956).Google Scholar
  20. 20.
    F.B.S. Palmer, Measurement of 32P following colorimetric phosphorus analysis. Anal’ Biochem 31:493 (1969).CrossRefGoogle Scholar
  21. 21.
    H.W. Moser and W.W. Chen, Ceramidase deficiency:Farber’s 1ipogranulomatosis,in Metabolic Basis of Inherited Disease, J. B. Stanbury, J.B. Wyngaarden, D.S. Fredrickson, J.L. Goldstein, and M.S. Brown (eds). 5 ed. New York:McGraw-Hi11 Book Co, p. 820. (1983).Google Scholar
  22. 22.
    J.C. Fratantoni, C.W. Hall, and E.F. Neufeld, The defect in Hurler’s and Hunter’s syndromes: faulty degradation of mucopolysaccharide. Proc Nat Acad Sci USA 60:699 (1968).PubMedCrossRefGoogle Scholar
  23. 23.
    J.A. Peterson and H. Rubin, The exchange of phospholipids between cultured chick embryo fibroblasts and their growth medium. Exp Cell Res 58:365 (1969).Google Scholar
  24. 24.
    Y.A. Hannun and R.M. Bell, Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235:670 (1987).PubMedCrossRefGoogle Scholar
  25. 25.
    W. Stoffel, Sphingosine metabolism and its link to phospholipid biosynthesis. Mol Cell Biochem 1:147 (1973).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • M. W. Spence
    • 1
  • H. W. Cook
    • 1
  • J. K. Burgess
    • 1
  1. 1.Departments of Pediatrics and Biochemistry and the Atlantic Research Centre for Mental RetardationDalhousie UniversityHalifax, Nova ScotiaCanada

Personalised recommendations